nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Erythema—Dexamethasone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Meropenem—Erythema—Betamethasone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Meropenem—Hallucination—Prednisone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Meropenem—Malaise—Triamcinolone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Meropenem—Malaise—Methylprednisolone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Meropenem—Syncope—Triamcinolone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Meropenem—Syncope—Methylprednisolone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Meropenem—Oedema—Prednisolone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Meropenem—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Meropenem—Neutropenia—Methotrexate—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Meropenem—Dysuria—Methotrexate—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Meropenem—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Meropenem—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Meropenem—Shock—Prednisolone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Meropenem—Cough—Triamcinolone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Meropenem—Tachycardia—Prednisolone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Meropenem—Hypertension—Triamcinolone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Meropenem—Hypertension—Methylprednisolone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Meropenem—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Meropenem—Pneumonia—Methotrexate—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Meropenem—Anxiety—Methylprednisolone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Meropenem—Infestation—Methotrexate—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Meropenem—Infestation NOS—Methotrexate—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Meropenem—Renal failure—Methotrexate—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Meropenem—Angioedema—Dexamethasone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Meropenem—Angioedema—Betamethasone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Meropenem—Confusional state—Methylprednisolone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Meropenem—Immune system disorder—Prednisone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Meropenem—Malaise—Dexamethasone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Meropenem—Malaise—Betamethasone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Meropenem—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Meropenem—Oedema—Triamcinolone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Meropenem—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Meropenem—Syncope—Dexamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Meropenem—Syncope—Betamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Meropenem—Infection—Triamcinolone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Meropenem—Sweating—Methotrexate—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Meropenem—Infection—Methylprednisolone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Meropenem—Shock—Triamcinolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Meropenem—Insomnia—Prednisolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Meropenem—Shock—Methylprednisolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Meropenem—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Meropenem—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Meropenem—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Meropenem—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Meropenem—Epistaxis—Methotrexate—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Meropenem—Paraesthesia—Prednisolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Meropenem—Tachycardia—Triamcinolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Meropenem—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Meropenem—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Meropenem—Erythema—Prednisone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Meropenem—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Meropenem—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Meropenem—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Meropenem—Hypertension—Dexamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Meropenem—Hypertension—Betamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Meropenem—Anxiety—Dexamethasone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Meropenem—Anxiety—Betamethasone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Meropenem—Haemoglobin—Methotrexate—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Meropenem—Hypotension—Methylprednisolone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Meropenem—Pain—Prednisolone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Meropenem—Haemorrhage—Methotrexate—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Meropenem—Hepatitis—Methotrexate—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Meropenem—Pharyngitis—Methotrexate—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Meropenem—Oedema—Dexamethasone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Meropenem—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Meropenem—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Meropenem—Oedema—Betamethasone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Meropenem—Insomnia—Triamcinolone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Meropenem—Insomnia—Methylprednisolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Meropenem—Infection—Dexamethasone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Meropenem—Infection—Betamethasone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Meropenem—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Meropenem—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Meropenem—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Meropenem—Anaemia—Prednisone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Meropenem—Shock—Dexamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Meropenem—Shock—Betamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Meropenem—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Meropenem—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Meropenem—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Meropenem—Agitation—Prednisone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Meropenem—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Meropenem—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Meropenem—Tachycardia—Dexamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Meropenem—Tachycardia—Betamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Meropenem—Angioedema—Prednisone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Meropenem—Dyspepsia—Triamcinolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Meropenem—Erythema multiforme—Methotrexate—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Meropenem—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Meropenem—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Meropenem—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Meropenem—Malaise—Prednisone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Meropenem—Syncope—Prednisone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Meropenem—Anorexia—Dexamethasone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Meropenem—Anorexia—Betamethasone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Meropenem—Urticaria—Prednisolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Meropenem—Pain—Triamcinolone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Meropenem—Loss of consciousness—Prednisone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Meropenem—Hypotension—Dexamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Meropenem—Hypotension—Betamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Meropenem—Immune system disorder—Methotrexate—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Meropenem—Hypertension—Prednisone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Meropenem—Chills—Methotrexate—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Meropenem—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Meropenem—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Meropenem—Anxiety—Prednisone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Meropenem—Insomnia—Dexamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Meropenem—Insomnia—Betamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Meropenem—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Meropenem—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Meropenem—Paraesthesia—Betamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Meropenem—Erythema—Methotrexate—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Meropenem—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Meropenem—Dyspepsia—Betamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Meropenem—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Meropenem—Urticaria—Triamcinolone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Meropenem—Urticaria—Methylprednisolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Meropenem—Dysgeusia—Methotrexate—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Meropenem—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Meropenem—Oedema—Prednisone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Meropenem—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Meropenem—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Meropenem—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Meropenem—Decreased appetite—Betamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Meropenem—Infection—Prednisone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Meropenem—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Meropenem—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Meropenem—Back pain—Methotrexate—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Meropenem—Shock—Prednisone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Meropenem—Pain—Betamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Meropenem—Pain—Dexamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Meropenem—Nervous system disorder—Prednisone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Meropenem—Tachycardia—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Meropenem—Skin disorder—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Meropenem—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Meropenem—Anorexia—Prednisone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Meropenem—Anaemia—Methotrexate—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Meropenem—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Meropenem—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Meropenem—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Meropenem—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Meropenem—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Meropenem—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Meropenem—Malaise—Methotrexate—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Meropenem—Leukopenia—Methotrexate—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Meropenem—Urticaria—Dexamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Meropenem—Urticaria—Betamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Meropenem—Dizziness—Prednisolone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Meropenem—Asthenia—Triamcinolone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Meropenem—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Meropenem—Abdominal pain—Betamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Meropenem—Body temperature increased—Betamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Meropenem—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Meropenem—Asthenia—Methylprednisolone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Meropenem—Insomnia—Prednisone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Meropenem—Paraesthesia—Prednisone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Meropenem—Pruritus—Triamcinolone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Meropenem—Cough—Methotrexate—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Meropenem—Pruritus—Methylprednisolone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Meropenem—Dyspepsia—Prednisone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Meropenem—Chest pain—Methotrexate—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Meropenem—Decreased appetite—Prednisone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Meropenem—Rash—Prednisolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Meropenem—Dermatitis—Prednisolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Meropenem—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Meropenem—Headache—Prednisolone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Meropenem—Constipation—Prednisone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Meropenem—Confusional state—Methotrexate—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Meropenem—Dizziness—Triamcinolone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Meropenem—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Meropenem—Dizziness—Methylprednisolone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Meropenem—Infection—Methotrexate—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Meropenem—Feeling abnormal—Prednisone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Meropenem—Asthenia—Betamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Meropenem—Asthenia—Dexamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Meropenem—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Meropenem—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Meropenem—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Meropenem—Nausea—Prednisolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Meropenem—Pruritus—Betamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Meropenem—Pruritus—Dexamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Meropenem—Skin disorder—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Meropenem—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Meropenem—Vomiting—Triamcinolone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Meropenem—Vomiting—Methylprednisolone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Meropenem—Rash—Triamcinolone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Meropenem—Dermatitis—Triamcinolone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Meropenem—Anorexia—Methotrexate—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Meropenem—Rash—Methylprednisolone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Meropenem—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Meropenem—Urticaria—Prednisone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Meropenem—Headache—Triamcinolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Meropenem—Headache—Methylprednisolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Meropenem—Abdominal pain—Prednisone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Meropenem—Body temperature increased—Prednisone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Meropenem—Diarrhoea—Betamethasone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Meropenem—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Meropenem—Hypotension—Methotrexate—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Meropenem—Dizziness—Betamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Meropenem—Dizziness—Dexamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Meropenem—Insomnia—Methotrexate—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Meropenem—Nausea—Triamcinolone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Meropenem—Paraesthesia—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Meropenem—Nausea—Methylprednisolone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Meropenem—Dyspnoea—Methotrexate—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Meropenem—Somnolence—Methotrexate—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Meropenem—Hypersensitivity—Prednisone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Meropenem—Dyspepsia—Methotrexate—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Meropenem—Vomiting—Betamethasone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Meropenem—Vomiting—Dexamethasone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Meropenem—Decreased appetite—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Meropenem—Rash—Betamethasone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Meropenem—Rash—Dexamethasone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Meropenem—Dermatitis—Dexamethasone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Meropenem—Dermatitis—Betamethasone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Meropenem—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Meropenem—Headache—Betamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Meropenem—Headache—Dexamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Meropenem—Asthenia—Prednisone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Meropenem—Pain—Methotrexate—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Meropenem—Pruritus—Prednisone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Meropenem—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00099	0.00099	CcSEcCtD
Meropenem—Diarrhoea—Prednisone—psoriatic arthritis	0.000984	0.000984	CcSEcCtD
Meropenem—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000983	0.000983	CcSEcCtD
Meropenem—Nausea—Betamethasone—psoriatic arthritis	0.000981	0.000981	CcSEcCtD
Meropenem—Nausea—Dexamethasone—psoriatic arthritis	0.000981	0.000981	CcSEcCtD
Meropenem—Urticaria—Methotrexate—psoriatic arthritis	0.000955	0.000955	CcSEcCtD
Meropenem—Dizziness—Prednisone—psoriatic arthritis	0.000951	0.000951	CcSEcCtD
Meropenem—Abdominal pain—Methotrexate—psoriatic arthritis	0.00095	0.00095	CcSEcCtD
Meropenem—Body temperature increased—Methotrexate—psoriatic arthritis	0.00095	0.00095	CcSEcCtD
Meropenem—Vomiting—Prednisone—psoriatic arthritis	0.000914	0.000914	CcSEcCtD
Meropenem—Rash—Prednisone—psoriatic arthritis	0.000907	0.000907	CcSEcCtD
Meropenem—Dermatitis—Prednisone—psoriatic arthritis	0.000906	0.000906	CcSEcCtD
Meropenem—Headache—Prednisone—psoriatic arthritis	0.000901	0.000901	CcSEcCtD
Meropenem—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000886	0.000886	CcSEcCtD
Meropenem—Asthenia—Methotrexate—psoriatic arthritis	0.000862	0.000862	CcSEcCtD
Meropenem—Nausea—Prednisone—psoriatic arthritis	0.000854	0.000854	CcSEcCtD
Meropenem—Pruritus—Methotrexate—psoriatic arthritis	0.00085	0.00085	CcSEcCtD
Meropenem—Diarrhoea—Methotrexate—psoriatic arthritis	0.000822	0.000822	CcSEcCtD
Meropenem—Dizziness—Methotrexate—psoriatic arthritis	0.000795	0.000795	CcSEcCtD
Meropenem—Vomiting—Methotrexate—psoriatic arthritis	0.000764	0.000764	CcSEcCtD
Meropenem—Rash—Methotrexate—psoriatic arthritis	0.000758	0.000758	CcSEcCtD
Meropenem—Dermatitis—Methotrexate—psoriatic arthritis	0.000757	0.000757	CcSEcCtD
Meropenem—Headache—Methotrexate—psoriatic arthritis	0.000753	0.000753	CcSEcCtD
Meropenem—Nausea—Methotrexate—psoriatic arthritis	0.000714	0.000714	CcSEcCtD
